T Cell News and Research

Latest T Cell News and Research

Researcher looks for clues to degenerative, deadly disease called Ataxia-telangiectasia

Few have heard of the degenerative, deadly disease called Ataxia-telangiectasia (A-T) but a University of Alberta researcher is hoping to provide clues to this mysterious disorder.

23 Sep 2004

32-year-old woman has given birth to a healthy baby 7 years after banking her ovarian tissue before starting chemotherapy

Although she became infertile as a result of the chemotherapy, re-implantation of her ovarian tissue re-started ovulation 5 months later; she became pregnant 11 months after re-transplantation by natural fertilization. Details of the procedure appear in a research article published online by THE LANCET.

23 Sep 2004

First generation of human retinal cells in the laboratory from human embryonic stem cells

Some of these retinal tissues such as Retinal Pigment Epithelium (RPE) may provide a novel therapeutic strategy for such devastating diseases as macular degeneration, retinitis pigmentosa, and other retinal degenerative diseases.

23 Sep 2004

Breakthrough discovery on why the malaria parasite has become resistant to chloroquine

Scientists at the Liverpool School of Tropical Medicine have made a major breakthrough in discovering why the malaria parasite Plasmodium Falciparum, deposited in humans by the mosquito, has become resistant to chloroquine

23 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Soy-rich foods could reduce the spread of breast cancer

Dr Pamela Magee, from the School of Biomedical Sciences, has been investigating the effects of a group of dietary compounds, found almost exclusively in soy foods, in the prevention of cancer spread

23 Sep 2004

Research may lead to alternatives to antibiotic drugs for treating bacterial diseases

UCLA microbiologists report the discovery of a new class of genetic elements, similar to retroviruses, that operate in bacteria, allowing them to diversify their proteins to bind to a large variety of receptors.

23 Sep 2004

Potential new way to control drug-resistant bacteria

The researchers, who encountered this genetic property while working on an unrelated project, believe that this discovery could lead to the use of genetically engineered phages to treat bacterial infections that have become resistant to antibiotics.

23 Sep 2004

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

Drinking a glass of red wine a day may cut a man's risk of prostate cancer in half, and the protective effect appears to be strongest against the most aggressive forms of the disease

23 Sep 2004

New link in the growth of Ewing’s sarcoma

To develop new therapeutic approaches to cancer, it is essential to understand the long and extremely complex process that underlies it, in other words the various stages of cancer development from the initial mutation to the tumor.

23 Sep 2004

NIH opens new hospital totally dedicated to clinical research

This new hospital totally dedicated to clinical research — research involving patients — is the most significant addition to the NIH campus in more than 50 years and provides a unique opportunity for scientists, clinicians, and patients to study and conquer both chronic and acute disease in the 21st century.

22 Sep 2004

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have prolonged the lives of mice with a rare blood disorder by using an experimental drug that blocks signals promoting runaway growth of blood cells.

21 Sep 2004

New gene therapy technique may help treat Alzheimer's disease

Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.

21 Sep 2004

Evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes

Endocrinologists from the University at Buffalo are providing one more link in the growing chain of evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes.

21 Sep 2004

Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process

Scientists at Dana-Farber Cancer Institute have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice.

21 Sep 2004

Stress response proteins offer a promising target for a novel drug guidance system

Their study, published in the September issue of the journal Cancer Cell, demonstrates how researchers can find protein tags that are unique to cancer cells and then tweak a drug delivery system to zero in on those tags and destroy the cells.

21 Sep 2004

HER-2 cell surface receptors tun on genes associated with carcinogenesis

Researchers at The University of Texas M. D. Anderson Cancer Center now have evidence that receptors found on tumors that were believed to function only on the surface of cells can actually switch on genes inside a cell's nucleus, thus promoting cancer development in two distinct ways.

21 Sep 2004

Streptococcus bacteria uses sword and shield to fight white blood cells

A single gene called cylE within the important bacterial pathogen Group B Streptococcus (GBS), controls two factors that act together as a “sword” and “shield” to protect the bacteria from the killing effects of the immune system’s white blood cells

21 Sep 2004

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy

Approximately half of patients with aggressive non-Hodgkin's lymphoma (NHL) fail to receive the recommended dose and schedule of chemotherapy, reducing their chances for remission or cure.

20 Sep 2004

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

The eradication of brain tumors in mice following treatment with a novel drug suggests that certain cancers might one day be cured without the use of toxic chemotherapy and radiation.

20 Sep 2004

T Cell News and Research

Latest T Cell News and Research

Researcher looks for clues to degenerative, deadly disease called Ataxia-telangiectasia

32-year-old woman has given birth to a healthy baby 7 years after banking her ovarian tissue before starting chemotherapy

First generation of human retinal cells in the laboratory from human embryonic stem cells

Breakthrough discovery on why the malaria parasite has become resistant to chloroquine

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Soy-rich foods could reduce the spread of breast cancer

Research may lead to alternatives to antibiotic drugs for treating bacterial diseases

Potential new way to control drug-resistant bacteria

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

New link in the growth of Ewing’s sarcoma

NIH opens new hospital totally dedicated to clinical research

Experimental drug PKC412 may be the key to treating myeloproliferative disease

New gene therapy technique may help treat Alzheimer's disease

Evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes

Scientists have corrected a flaw in cancer cells that lets them evade the normal cell-death process

Stress response proteins offer a promising target for a novel drug guidance system

HER-2 cell surface receptors tun on genes associated with carcinogenesis

Streptococcus bacteria uses sword and shield to fight white blood cells

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy

Certain cancers might one day be cured without the use of toxic chemotherapy and radiation

Immunology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in